BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9707024)

  • 1. Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma.
    von Neuhoff N; Dreger P; Suttorp M; Marget M; Kell S; Schmitz N
    Bone Marrow Transplant; 1998 Jul; 22(2):161-6. PubMed ID: 9707024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation.
    Hirt C; Dölken G
    Bone Marrow Transplant; 2000 Feb; 25(4):419-26. PubMed ID: 10723586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
    González-Barca E; Fernández de Sevilla A; Domingo-Claros A; Romagosa V; Martín-Henao GA; De Sanjose S; Carmona M; Petit J; García J; Grañena A
    Bone Marrow Transplant; 2000 Nov; 26(10):1051-6. PubMed ID: 11108302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course.
    Chang CC; Bredeson C; Juckett M; Logan B; Keever-Taylor CA
    Bone Marrow Transplant; 2003 Aug; 32(3):287-91. PubMed ID: 12858200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
    Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
    Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes].
    al Saati T; Galoin S; Roda D; Huynh A; Attal M; Delsol G
    Bull Cancer; 1998 Oct; 85(10):847-54. PubMed ID: 9835862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells.
    McGregor DK; Keever-Taylor CA; Bredeson C; Schur B; Vesole DH; Logan B; Chang CC
    Bone Marrow Transplant; 2005 Jun; 35(11):1049-54. PubMed ID: 15821762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant.
    Rosenblum MD; Drobyski WR; Keever-Taylor C; Chang CC
    Bone Marrow Transplant; 2003 May; 31(10):947-9. PubMed ID: 12748676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
    Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
    Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Practical aspects and clinical value of t(14;18) monitoring in peripheral blood of the follicular lymphoma patients].
    Janíková-Oborilová A; Mayer J; Dvorákova D; Mejstrík P; Navritíl M; Vásová I; Kren L; Matuska M
    Cas Lek Cesk; 2007; 146(4):374-81; discussion 381-2. PubMed ID: 17491248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
    Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction.
    Pennell N; Woods A; Reis M; Buckstein R; Spaner D; Imrie K; Hewitt K; Boudreau A; Seth A; Berinstein NL
    J Mol Diagn; 2006 Feb; 8(1):40-50. PubMed ID: 16436633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection and diagnostic value of t(14;18) translocation in minimal residual disease of follicular lymphoma].
    Bessenyei B; Urbán L; Takács I; Zeher M; Szegedi G; Semsei I
    Orv Hetil; 2000 Jul; 141(31):1715-9. PubMed ID: 10976195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for stem cell transplantation in indolent lymphomas.
    Gribben JG
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S37-45. PubMed ID: 9672773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients.
    Tysarowski A; Fabisiewicz A; Paszkiewicz-Kozik E; Kulik J; Walewski J; Siedlecki JA
    Acta Biochim Pol; 2007; 54(1):135-42. PubMed ID: 17351675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
    Darby A; Gribben JG
    Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.